The current contribution of molecular factors to risk estimation in neuroblastoma patients. - Berthold,F.; Sahin,K.; Hero,B.; Christiansen,H.; Gehring,M.; Harms,D.; Horz,S.; Lampert,F.; Schwab,M.; Terpe,J. (Eur J Cancer, 1997)